MaxioCel®

MaxioCel® is a company focused on advanced wound care, offering innovative wound dressings that utilize proprietary Bioactive Microfiber Gelling (BMG®) Technology. Their flagship product, MaxioCel, is a 100% chitosan-based dressing designed to support healing for both acute and chronic wounds. This dressing addresses all four phases of wound healing and integrates antimicrobial protection, exudate management, pain relief, and scar improvement into a single solution. The dressings are made from chitosan, a biomaterial known for its biocompatibility and bioactive properties. Upon contact with wound exudate, MaxioCel transforms into a soothing gel matrix that helps reduce inflammation and promotes tissue regeneration, leading to improved patient comfort and faster healing. The product range is suitable for various wound types, including diabetic foot ulcers, pressure ulcers, and surgical wounds. MaxioCel is available in over 50 countries and is designed for use by healthcare providers such as hospitals, clinics, and wound care specialists.

• Employees 0
• Founded 2019